Ignacio Duran

8PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 11, 2023
Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience.

Marina Serrano, Nerea Muñoz-Unceta, Lucía Andrea Alonso

|Aug 03, 2023
Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution.

Marta Sotelo, Nerea Muñoz-Unceta, Antonio Matorras

|Jul 26, 2022
Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel.

Daniel Herrero Rivera, Carmen Garrigós Vacas, Laura Marcos Kovandzic

|Mar 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.

Jörg Beyer, Laurence Collette, Nicolas Sauvé

|Sep 08, 2020
Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies.

M Sotelo, T Alonso-Gordoa, P Gajate

Pageof 2